The molecular landscape of head and neck cancer. (Q52678178)

5 May 2018

title

The molecular landscape of head and neck cancer. (English)

1 reference

5 May 2018

1

C René Leemans

1 reference

5 May 2018

Peter J F Snijders

series ordinal

2

object named as

Peter J F Snijders

1 reference

5 May 2018

author name string

Ruud H Brakenhoff

series ordinal

3

1 reference

5 May 2018

language of work or name

English

0 references

publication date

2 March 2018

1 reference

5 May 2018

published in

Nature Reviews Cancer

1 reference

5 May 2018

volume

18

1 reference

5 May 2018

issue

5

1 reference

5 May 2018

page(s)

269-282

1 reference

5 May 2018

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Comprehensive genomic characterization of head and neck squamous cell carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Human papillomavirus and survival of patients with oropharyngeal cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Hallmarks of Cancer: The Next Generation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

The molecular biology of head and neck cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

31 March 2020

Cancer genome landscapes

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Pooled estimate of world leukoplakia prevalence: a systematic review.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Natural history of potentially malignant oral lesions and conditions: an overview of the literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Multiple head and neck tumors frequently originate from a single preneoplastic lesion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Loss of heterozygosity (LOH) profiles--validated risk predictors for progression to oral cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Loss of heterozygosity at 9p and p53 immunopositivity in surgical margins predict local relapse in head and neck squamous cell carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

The Case for a Pre-Cancer Genome Atlas (PCGA).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Mutated p53 as a molecular marker for the diagnosis of head and neck cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Interfollicular epidermal stem cells self-renew via autocrine Wnt signaling.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Genomic insights into head and neck cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Genetic Landscape of Human Papillomavirus-Associated Head and Neck Cancer and Comparison to Tobacco-Related Tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Replication Catastrophe: When a Checkpoint Fails because of Exhaustion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

The first 30 years of p53: growing ever more complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Epidermal growth factor receptor (EGFR) signaling in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Nuclear localization of EGF receptor and its potential new role as a transcription factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Functional kinomics identifies candidate therapeutic targets in head and neck cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

The cell-cell adhesion molecule E-cadherin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Mammalian Fat1 cadherin regulates actin dynamics and cell-cell contact

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Stem cell signaling. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

The LIM protein Ajuba is recruited to cadherin-dependent cell junctions through an association with alpha-catenin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Ajuba, a cytosolic LIM protein, shuttles into the nucleus and affects embryonal cell proliferation and fate decisions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Ajuba negatively regulates the Wnt signaling pathway by promoting GSK-3beta-mediated phosphorylation of beta-catenin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

The canonical Notch signaling pathway: unfolding the activation mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

From fly wings to targeted cancer therapies: a centennial for notch signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

The mutational landscape of head and neck squamous cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Activation of the NOTCH pathway in head and neck cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Notch1 functions as a tumor suppressor in mouse skin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Notch post-translationally regulates β-catenin protein in stem and progenitor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Epigenetic control of gene expression: Potential implications for cancer treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Haploinsufficiency of NSD1 causes Sotos syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

NSD1 mutations generate a genome-wide DNA methylation signature.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

MicroRNA biogenesis pathways in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Targeting PLK1 as a novel chemopreventive approach to eradicate preneoplastic mucosal changes in the head and neck.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Chemical Proteomics Identifies Druggable Vulnerabilities in a Genetically Defined Cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Presence of DNA of human papillomavirus 16 but no other types in tumor-free tonsillar tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Human papillomavirus infection is rare in nonmalignant tonsil tissue in the UK: implications for tonsil cancer precursor lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Prevalence of human papillomavirus in tonsil brushings and gargles in cancer-free patients: The SPLIT study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Prevalence of oral HPV infection in the United States, 2009-2010.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Cytokeratin 7 in Oropharyngeal Squamous Cell Carcinoma: A Junctional Biomarker for Human Papillomavirus-Related Tumors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Characterization of Epithelial Progenitors in Normal Human Palatine Tonsils and Their HPV16 E6/E7-Induced Perturbation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

HPV16 Sublineage Associations With Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Immortalization of oral keratinocytes by functional inactivation of the p53 and pRb pathways.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Oncogenic PI3K deregulates transcription and translation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Reverse-phase protein array profiling of oropharyngeal cancer and significance of PIK3CA mutations in HPV-associated head and neck cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

PIK3CA-mediated PI3-kinase signalling is essential for HPV-induced transformation in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Overexpression of PIK3CA in murine head and neck epithelium drives tumor invasion and metastasis through PDK1 and enhanced TGFβ signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Somatic mutation in PIK3CA is a late event in cervical carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Subtypes of HPV-Positive Head and Neck Cancers Are Associated with HPV Characteristics, Copy Number Alterations, PIK3CA Mutation, and Pathway Signatures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Pan-cancer analysis of the extent and consequences of intratumor heterogeneity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

CD98 marks a subpopulation of head and neck squamous cell carcinoma cells with stem cell properties

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Cancer stem cell enrichment marker CD98: a prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

CD44 expression predicts local recurrence after radiotherapy in larynx cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Detection of circulating tumor DNA in early- and late-stage human malignancies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Tumor-derived exosomes and microvesicles in head and neck cancer: implications for tumor biology and biomarker discovery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Expression signature in peripheral blood cells for molecular diagnosis of head and neck squamous cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Immunology and Immunotherapy of Head and Neck Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

The genomic landscapes of human breast and colorectal cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Mutational heterogeneity in cancer and the search for new cancer-associated genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

An integrated genomic analysis of human glioblastoma multiforme

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

From HPV-positive towards HPV-driven oropharyngeal squamous cell carcinomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Oropharyngeal cancer, human papilloma virus, and clinical trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2018.11

Genetic progression model for head and neck cancer: implications for field cancerization

31 March 2020

1 reference

12 December 2020

Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications.

1 reference

12 December 2020

Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays.

1 reference

12 December 2020

Case-control study of human papillomavirus and oropharyngeal cancer

1 reference

12 December 2020

Oral human papillomavirus in healthy individuals: a systematic review of the literature

1 reference

12 December 2020

Ajuba family proteins link JNK to Hippo signaling.

1 reference

12 December 2020

The Notch intracellular domain integrates signals from Wnt, Hedgehog, TGFβ/BMP and hypoxia pathways

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRC.2018.11

1 reference

5 May 2018

1 reference

5 May 2018